Trial Profile
A Study Investigating a Short Duration of Ledipasvir-Sofosbuvir Therapy (8 weeks) in Hepatitis C-Virus (HCV) Genotype 1a Patients with HIV Co-Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 Jan 2018 New trial record